FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Intersect ENT Sinuva Recall

SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, inte…

Intersect ENT, Inc. · Menlo Park, CA

Risk level
Class III
Reported by FDA
Jan 25, 2023
Recall ID
D-0167-2023
Check your lot numberHow we source this data

Summary

Intersect ENT recalled Sinuva starting Jan 4, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0167-2023 on Jan 25, 2023. Reason: Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months. Status: Terminated.

Why it was recalled

Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.

Product description

SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025, NDC 10599-003-01.

Lot numbers, UPCs & expiration codes

Lot #s: 10111003, Exp 12/31/2022; 10203002, Exp 01/31/2023; 10302002, 10325001, Exp 02/28/2023; 10519001, 10526002, Exp 04/30/2023; 10602002, Exp 05/31/2023; 10819004, Exp 09/30/2023; 21092101, 21111901, Exp 10/31/2023; 21110402, Exp 12/31/2023.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0167-2023
Classification
Class III
Status
Terminated
Recall initiated
Jan 4, 2023
FDA report date
Jan 25, 2023
Quantity
9898 pouches
Recall type
Voluntary: Firm initiated
Recalling firm
Intersect ENT, Inc.

Original FDA data

Every field from FDA enforcement report D-0167-2023, exactly as published.

Show all FDA fields
City
Menlo Park
State
CA
Status
Terminated
Country
United States
Event ID
91348
Address
1555 Adams Dr
Code information
Lot #s: 10111003, Exp 12/31/2022; 10203002, Exp 01/31/2023; 10302002, 10325001, Exp 02/28/2023; 10519001, 10526002, Exp 04/30/2023; 10602002, Exp 05/31/2023; 10819004, Exp 09/30/2023; 21092101, 21111901, Exp 10/31/2023; 21110402, Exp 12/31/2023.
Postal code
94025-1439
Report date
Jan 25, 2023
Product type
Drugs
Recall number
D-0167-2023
Classification
Class III
Recalling firm
Intersect ENT, Inc.
Product quantity
9898 pouches
Termination date
Aug 21, 2024
Reason for recall
Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.
Voluntary / mandated
Voluntary: Firm initiated
Product description
SINUVA (mometasone furoate) sinus implant, 1350 mcg, 1 implant per pouch, Rx Only, intersect ENT, 1555 Adams Drive, Menlo Park, CA 94025, NDC 10599-003-01.
Distribution pattern
Nationwide
Recall initiation date
Jan 4, 2023
Initial firm notification
Letter
Center classification date
Jan 19, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0167-2023, published Jan 25, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls